Literature DB >> 21825225

Inhibition of prolyl hydroxylase domain-containing protein: a novel therapy for cardiovascular diseases?

Takehiko Takayanagi, Satoru Eguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21825225      PMCID： PMC3197266          DOI： 10.1161/HYPERTENSIONAHA.111.177949

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells.

Authors:  D E Richard; E Berra; J Pouyssegur
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

2.  Intermittent hypoxia increases arterial blood pressure in humans through a Renin-Angiotensin system-dependent mechanism.

Authors:  Glen E Foster; Patrick J Hanly; Sofia B Ahmed; Andrew E Beaudin; Vincent Pialoux; Marc J Poulin
Journal:  Hypertension       Date:  2010-07-12       Impact factor: 10.190

Review 3.  Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure.

Authors:  E C Fletcher
Journal:  J Appl Physiol (1985)       Date:  2001-04

4.  Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells.

Authors:  Chhinder P Sodhi; Yashpal S Kanwar; Atul Sahai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11-14       Impact factor: 4.733

5.  Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor.

Authors:  Hirohide Matsuura; Toshihiro Ichiki; Jiro Ikeda; Kotaro Takeda; Ryohei Miyazaki; Toru Hashimoto; Eriko Narabayashi; Shiro Kitamoto; Tomotake Tokunou; Kenji Sunagawa
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

Review 6.  Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.

Authors:  Carmine Savoia; Ernesto L Schiffrin
Journal:  Clin Sci (Lond)       Date:  2007-06       Impact factor: 6.124

7.  Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.

Authors:  Kotaro Takeda; Toshihiro Ichiki; Eriko Narabayashi; Keita Inanaga; Ryohei Miyazaki; Toru Hashimoto; Hirohide Matsuura; Jiro Ikeda; Toshio Miyata; Kenji Sunagawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-17       Impact factor: 8.311

8.  Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.

Authors:  Qingwei Zhao; Minako Ishibashi; Ken-ichi Hiasa; Chunyan Tan; Akira Takeshita; Kensuke Egashira
Journal:  Hypertension       Date:  2004-07-19       Impact factor: 10.190

9.  Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice.

Authors:  Ela Karshovska; Alma Zernecke; Gueler Sevilmis; Andrea Millet; Mihail Hristov; Clemens D Cohen; Holger Schmid; Florian Krotz; Hae-Young Sohn; Volker Klauss; Christian Weber; Andreas Schober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-11       Impact factor: 8.311

Review 10.  Role and regulation of prolyl hydroxylase domain proteins.

Authors:  G-H Fong; K Takeda
Journal:  Cell Death Differ       Date:  2008-02-15       Impact factor: 15.828
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.